HB456 - Fairness in Orphan Drug Exclusivity Act
US Congress - 118th Congress
Introduced byEarl L. Carter
Last updated over 1 year ago
1 Co-Sponsor
To amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now